Journal Logo

Reviews & Controversies

  • Updated:   6/9/2022
  • Contains:  79 items
Below is a collection of all Review and Controversy articles published by HemaSphere. This collection is regularly updated with each monthly issue.

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Delgado, Julio; Papadouli, Irene; Sarac, Sinan B.; More

HemaSphere. 5(12):e666, December 2021.

The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia

Delgado, Julio; Voltz, Caroline; Stain, Milena; More

HemaSphere. 5(8):e616, August 2021.

The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease

Delgado, Julio; Voltz, Caroline; Stain, Milena; More

HemaSphere. 5(7):e604, July 2021.

Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions

Valent, Peter; Orfao, Alberto; Kubicek, Stefan; More

HemaSphere. 5(3):e536, March 2021.

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Dimopoulos, Meletios A.; Moreau, Philippe; Terpos, Evangelos; More

HemaSphere. 5(2):e528, February 2021.

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; More

HemaSphere. 4(5):e473, October 2020.

Recommendations for Pregnancy in Rare Inherited Anemias

Taher, Ali T.; Iolascon, Achille; Matar, Charbel F.; More

HemaSphere. 4(4):e446, August 2020.

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Talaulikar, Dipti; Advani, Ranjana H.; Branagan, Andrew R.; More

HemaSphere. 4(4):e433, August 2020.

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

Daw, Stephen; Hasenclever, Dirk; Mascarin, Maurizio; More

HemaSphere. 4(1):e329, February 2020.

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; More

HemaSphere. 3(6):e321, December 2019.

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

Rodeghiero, Francesco; Pabinger, Ingrid; Ragni, Margaret; More

HemaSphere. 3(5):e286, October 2019.

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

Bizymi, Nikoleta; Bjelica, Suncica; Kittang, Astrid Olsnes; More

HemaSphere. 3(1):e168, February 2019.

Insights on Multiple Myeloma Treatment Strategies

Mateos, María-Victoria; Ludwig, Heinz; Bazarbachi, Ali; More

HemaSphere. 3(1):e163, February 2019.

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet

Itzykson, Raphael; Fenaux, Pierre; Bowen, David; More

HemaSphere. 2(6):e150, December 2018.

Show: